SERBEHISTIN betahistine dihydrochloride 16 mg tablets blister packs

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

betahistine dihydrochloride, Quantity: 16 mg

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

betahistine dihydrochloride

Darreichungsform:

Tablet, uncoated

Zusammensetzung:

Excipient Ingredients: colloidal anhydrous silica; purified talc; microcrystalline cellulose; mannitol; citric acid

Verabreichungsweg:

Oral

Einheiten im Paket:

25 tablets, 30 tablets, 100 tablets, 10 tablets, 60 tablets

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Meniere's Syndrome as defined by the following core symptoms: vertigo (with nausea/vomiting), hearing loss (hardness of hearing) and tinnitus.

Produktbesonderheiten:

Visual Identification: Uncoated, round, biconvex, white to light creamy tablets, with a groove on one surface.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2014-08-14